Many VCA Inc.(WOOF) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. VCA Inc was Downgraded by CL King to Neutral on Jan 26, 2017. VCA Inc was Downgraded by Credit Suisse to Neutral on Jan 11, 2017. VCA Inc was Downgraded by Raymond James to Mkt Perform on Jan 10, 2017. VCA Inc was Upgraded by Raymond James to Strong Buy on Jan 3, 2017.
Company has reported several Insider transactions to the SEC, on Sep 19, 2016, Arthur J Antin (COO & Senior VP) sold 34,000 shares at 69.03 per share price.On Sep 8, 2016, Josh Drake (President, Antech Diagnostics) sold 14,584 shares at 72.01 per share price.On Sep 6, 2016, Tomas W Fuller (CFO, VP & Secretary) sold 47,544 shares at 70.59 per share price.
VCA Inc Last issued its quarterly earnings results on Feb 9, 2017. The company reported $0.58 EPS for the quarter, missing the analyst consensus estimate by $ -0.02. Analyst had a consensus of $0.60. The company had revenue of $643.10 million for the quarter, compared to analysts expectations of $642.85 million. The companys revenue was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.50 EPS.
VCA Inc. (NASDAQ:WOOF) has received a short term rating of sell from experts at Zacks with a rank of 4. The stock has been rated an average of 2.43 by 7 Brokerage Firm. 2 Wall Street Firms have rated the stock as a strong buys. 5 Brokerage Firms have advised hold.
VCA Inc. (NASDAQ:WOOF): 5 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $86 in VCA Inc. (NASDAQ:WOOF). However, the stock price could fluctuate by $ 8.34 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $93 price target with the lower price estimate is calculated at $76
VCA Inc. (NASDAQ:WOOF) witnessed a decline in the market cap on Tuesday as its shares dropped 0.02% or 0.02 points. After the session commenced at $90.75, the stock reached the higher end at $90.83 while it hit a low of $90.75. With the volume soaring to 1,001,022 shares, the last trade was called at $90.77. The company has a 52-week high of $91.58. The company has a market cap of $7,404 million and there are 81,573,526 shares in outstanding. The 52-week low of the share price is $48.75.
VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California.